Kehinde A. Adekola

Hematology | Oncology

675 N St Clair St Ste 21-100
Galter Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology.

Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: February 11, 2026

NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.

NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: May 09, 2025

Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia.

Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia.

Journal: Blood

Published: November 04, 2024

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: January 20, 2024

Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: December 11, 2023

Evaluating Socioeconomic, Racial, and Ethnic Disparities in Survival Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplants.

Evaluating Socioeconomic, Racial, and Ethnic Disparities in Survival Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplants.

Journal: Journal of racial and ethnic health disparities

Published: February 21, 2023

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease.

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease.

Journal: Blood advances

Published: January 27, 2023

Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.

Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.

Journal: BMC cancer

Published: January 26, 2023

Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: January 18, 2023

Examining the Efficacy of Bright Light Therapy on Cognitive Function in Hematopoietic Stem Cell Transplant Survivors.

Examining the Efficacy of Bright Light Therapy on Cognitive Function in Hematopoietic Stem Cell Transplant Survivors.

Journal: Journal of biological rhythms

Published: July 29, 2022

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.

Journal: Blood

Published: May 06, 2022

NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.

NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: January 06, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026